Orthopaedic Industry News & Orthopaedic Company News | Orthogate Professionals

Here are six takeaways:

1. The aging population and increasing number of neurological disorder cases will spur market growth in the forecast period.

2. A dearth of skilled professionals in developing countries as well as unfavorable reimbursements will hinder the market.

3. Currently, North America dominates the market, because of the high neurosurgical case volume in this region.

4. Europe follows North America in market share, because of its technological advancements in the healthcare industry.

5. The Asia-Pacific region is anticipated to grow, due to market opportunity in India and China.

6. Key market players include:

CHARLOTTESVILLE, Va. (NEWSPLEX) -- A national list says part of the University of Virginia Medical Center is one of the best in the country.

UVA Orthopedics was listed as one of the Becker's Hospital Review's 100 Hospitals with Great Orthopedic Programs 2016.

"I'm thrilled to see our team at UVA receive this national honor for our work to provide excellent, comprehensive care to patients throughout the region," said Bobby Chhabra, MD, chair of the UVA Department of Orthopedic Surgery.

Becker's says the hospitals included on its list have been recognized for excellence from various other publications and industry organizations, including U.S.

VANCOUVER, BC--(Marketwired - November 10, 2016) -According to a new series of reports on the U.S. market for anesthesia, respiratory and sleep management (ARS) devices by iData Research (www.idataresearch.com), the market is largely influenced by insurance policies, especially when it comes to durable devices governed under the durable manufacturer equipment (DME) realm. Beginning in January of 2016, the U.S. Congress dramatically cut reimbursement for home oxygen services by applying competitive rates in geographic areas that were previously excluded from competitive bidding. Some providers of home oxygen therapy have already started planning in order to stay operational in the face of such drastic shortfalls, which could result in the elimination of many of the critical services upon which patients have come to depend.

VANCOUVER, BC--(Marketwired - November 10, 2016) - According to a new series of reports on the U.S. market for anesthesia, respiratory and sleep management (ARS) devices by iData Research (www.idataresearch.com), the market is largely influenced by insurance policies, especially when it comes to durable devices governed under the durable manufacturer equipment (DME) realm. Beginning in January of 2016, the U.S. Congress dramatically cut reimbursement for home oxygen services by applying competitive rates in geographic areas that were previously excluded from competitive bidding. Some providers of home oxygen therapy have already started planning in order to stay operational in the face of such drastic shortfalls, which could result in the elimination of many of the critical services upon which patients have come to depend.

Here's what you need to know.

1. HHS Inspector General Daniel R. Levinson told Senator Charles Grassley (R-Iowa) of the findings Oct. 8, 2016. Mylan agreed to a $465 million settlement with CMS last month.

2. The disclosure from HHR raise questions on why Mylan took so long to correct the error, what steps CMS took to inform Mylan of the error and why Mylan didn't disclose the information with its investors.

3. U.S. Securities regulators issued a subpoena for Mylan's communications with CMS.